Latest approvals from MHRA Health Advisory & Recovery Team | December 11, 2022 This week over one hundred health professionals wrote to the MHRA regarding Moderna’s application for a conditional marketing authorisation for Spikevax for babies from 6 months upwards. This baby dose has already been approved in the US and added to their routine immunisation schedule, […]
Source